Archive for the ‘ExL Events News’ Category
Before she takes that podium at our 4th Rx-to-OTC Switch Summit, Susan B. Levy Consulting’s Founder and Principal, Susan Levy, sat down with ExL to discuss the OTC market and pre-launch preparation. Take a look here:
You’ve been involved in ExL Events’ Rx-to-OTC Summit since 2014 — what has changed since then and what brings you back?
Since 2014, we’ve seen additional switches in existing OTC categories, including Flonase, Nexium, Rhinocort, and Xyzal. Some of these switches have been more successful than others. We’ve also seen two Advisory Committee Meetings. Singulair failed to…
Industry Leaders From Pfizer, Merck and Pacira Share Insights at the Value-Based Reimbursement Event!
The methodical challenges faced by market access professionals can vastly differ by therapeutic area, size of the organization, and the number of resources available to them. Cookie-cutter solutions cannot address the unique challenges faced by a company. It is critical that the education available to market access professionals meets the varying needs of the industry. Don’t worry — leaders from Pfizer, Merck, Pacira and more share insights at our Value-Based Reimbursement event.
The speaking faculty at ExL’s Value-Based Strategies for Reimbursement and Formulary Success conference consists of executives from pharmaceutical…
ExL’s premier co-located event series, taking place October 26–27 in Boston, features three conferences, 50+ speakers, and two days of shared networking with 150+ industry executives. These three conferences will bring together experts from nonprofits, NGOs, academia, pharmaceutical companies and biotechs to discuss the balance between social equity and business goals.
The Non-Profit/NGO/Academic rate is 40% off the standard registration price for all of the below conferences…
* To receive this discount, please use Discount Code 2017NP
View the agenda…
Neglected Tropical Diseases Forum: GSK, Merck, and More Discuss Strategic Partnerships in Global Health Programs
The Neglected Tropical Diseases Forum, taking place on October 26–27, 2017 in Boston, is the premier event for building strategic partnerships to support global health programs across the biomedical landscape. Attendees will hear case studies about strategies that support sustained funding and help overcome clinical development and regulatory challenges associated with NTD treatments and diagnostics.
Review all of the session topics and presentations in our agenda here.
Michael Eichberg, Director, Strategic Alliances, Merck, will be discussing experiences with synergistic partnerships to combat the Ebola outbreak.
Shelly O’Donovan, Former…
The Innovative Regulatory Pathways Summit is taking place January 29–30, 2018 in Arlington, VA. This intimate summit will bring together leading regulatory experts and senior-level executives to discuss regulatory strategies to expedite drug development in the U.S., EU, and Japan. Download the brochure here to review the sessions and speakers featured at this event.
Breakthrough therapy designations and other expedited pathways encourage sponsors to increase communication and collaboration with the FDA. Expedited drug development options are also available globally in ICH countries…
ExL Events is excited to announce the Cannabis Partnerships Congress, taking place March 12–13, 2018 in San Francisco, CA! The Cannabis Congress is an educational forum designed to bring all stakeholders involved in the cannabis-based scientific, medicinal, governmental, and product development to fortify the therapies in a collaborative environment.
Despite recent changes in state policy, and with the increasing rate of cannabis use and its implications for health, the government has yet to legalize cannabis. With the continued enforcement of restrictive policies and regulations on research into the health benefits, it is important…
The Innovative Regulatory Pathways Summit is taking place January 29–30, 2018 in Arlington, VA! This intimate summit will bring together leading regulatory experts and senior-level executives to discuss breakthrough therapy designations and other regulatory strategies to expedite patient drug development in the U.S., EU, and Japan. Download the brochure here to review the sessions and speakers featured at this event.
Join our professional speaking faculty, which includes representatives from:
Since the release of the brochure for ExL’s Value-Based Strategies for Reimbursement and Formulary Success, recent news has emerged, highlighting the pressure placed on life science organizations to account for the healthcare value of drugs in reimbursement strategies. In an era of performance-driven healthcare, we have continued to follow this topic in the news. The below articles address current events in formulary access and reimbursement strategies and highlight the importance of staying up to date with industry developments.
Will the UK’s Post-Brexit Life Sciences Strategy Be a Boon for Market Access?
The highly anticipated life sciences strategy commissioned by the UK government…
Starting or changing medication can be stressful for patients, especially if there is a communication barrier between them and their physician. While doctors, nurses, pharmacists and other professionals in the fields of medicine understand side effects and reactions that come with certain medications, a patient most likely does not. Taking their point of view into consideration is paramount for patient-centric care and successful treatments.
According to a recent article published by the BBC, people usually have negative responses to medical information pamphlets and the like. A new report states that patients find this form of communicating side…
ExL Events is proud to announce that Elizabeth “EJ” Ashbourne (Executive Director, PQMD) is set to speak and lead an interactive roundtable at the Neglected Tropical Diseases Forum this October 26–27 in Boston. This conference is dedicated to the multi–sector partnerships that combat NTDs and build a community of practice.
“I am participating in this forum because I am passionate about bringing together global health professionals, across the biomedical landscape, to discuss best practices for building programs to combat NTDs. This will…
From The Blog
- Commercial Strategy
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Public/Government Relations
- Regulatory Affairs